Publications - Ryan J . Uitti, M.D.

Back to Research Profile

1. Wider C, Vilarino-Guell C, Jasinska-Myga B, Heckman MG, Soto-Ortolaza AI, Cobb SA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Association of the MAPT locus with Parkinson's disease. Eur J Neurol 2009 Nov 12. [Epub ahead of print]
   View PubMed
2. Cobb SA, Wider C, Ross OA, Mata IF, Adler CH, Rajput A, Rajput AH, Wu RM, Hauser R, Josephs KA, Carr J, Gwinn K, Heckman MG, Aasly JO, Lynch T, Uitti RJ, Wszolek ZK, Kapatos G, Farrer MJ. GCH1 in early-onset Parkinson's disease. Mov Disord 2009 Oct 30; 24(14):2070-5.
   View PubMed
3. Keeling BH, Vilarino-Guell C, Soto-Ortolaza AI, Ross OA, Uitti RJ, Rajput A, Wszolek ZK, Farrer MJ. Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremor. Parkinsonism Relat Disord 2009 Sep 19. [Epub ahead of print]
   View PubMed
4. Keeling BH, Vilarino-Guell C, Ross OA, Wszolek ZK, Uitti RJ, Farrer MJ. DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease. Neurosci Lett 2009 Sep 18; 461(2):74-5. Epub 2009 Jun 12.
   View PubMed
5. Vilarino-Guell C, Ross OA, Wider C, Jasinska-Myga B, Cobb SA, Soto-Ortolaza AI, Kachergus JM, Keeling BH, Dachsel JC, Melrose HL, Behrouz B, Wszolek ZK, Uitti RJ, Aasly JO, Rajput A, Farrer MJ. LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism Relat Disord 2009 Aug 31. [Epub ahead of print]
   View PubMed
6. Soto-Ortolaza AI, Behrouz B, Wider C, Vilarino-Guell C, Heckman MG, Aasly JO, Mark Gibson J, Lynch T, Jasinska-Myga B, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Calbindin-1 association and Parkinson's disease. Eur J Neurol 2009 Aug 05. [Epub ahead of print]
   View PubMed
7. Jasinska-Myga B, Wider C, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Baker M, Rademakers R, Uitti RJ, Farrer MJ, Ross OA, Wszolek ZK. GRN 3'UTR+78 C>T is not associated with risk for Parkinson's disease. Eur J Neurol 2009 Aug; 16(8):909-11. Epub 2009 Mar 31.
   View PubMed
8. Golub Y, Berg D, Calne DB, Pfeiffer RF, Uitti RJ, Stoessl AJ, Wszolek ZK, Farrer MJ, Mueller JC, Gasser T, Fuchs J. Genetic factors influencing age at onset in LRRK2-linked Parkinson disease. Parkinsonism Relat Disord 2009 Aug; 15(7):539-41. Epub 2008 Nov 28.
   View PubMed
9. Vilarino-Guell C, Chai H, Keeling BH, Young JE, Rajput A, Lynch T, Aasly JO, Uitti RJ, Wszolek ZK, Farrer MJ, Lin SC. MEIS1 p.R272H in familial restless legs syndrome. Neurology 2009 Jul 21; 73(3):243-5.
   View PubMed
10. Vilarino-Guell C, Wider C, Soto-Ortolaza AI, Cobb SA, Kachergus JM, Keeling BH, Dachsel JC, Hulihan MM, Dickson DW, Wszolek ZK, Uitti RJ, Graff-Radford NR, Boeve BF, Josephs KA, Miller B, Boylan KB, Gwinn K, Adler CH, Aasly JO, Hentati F, Destee A, Characterization of DCTN1 genetic variability in neurodegeneration. Neurology 2009 Jun 9; 72(23):2024-8.
    View PubMed
11. Slowinski JL, Schweitzer KJ, Imamura A, Uitti RJ, Strongosky AJ, Dickson DW, Broderick DF, Wszolek ZK. Brainstem atrophy on routine MR study in pallidopontonigral degeneration. J Neurol 2009 May; 256(5):827-9 Epub 2009 Mar 1.
    View PubMed
12. Wider C, Lincoln SJ, Heckman MG, Diehl NN, Stone JT, Haugarvoll K, Aasly JO, Gibson JM, Lynch T, Rajput A, Rajput ML, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Phactr2 and Parkinson's disease. Neurosci Lett 2009 Mar 27; 453(1):9-11. Epub 2009 Feb 10.
    View PubMed
13. Haugarvoll K, Toft M, Skipper L, Heckman MG, Crook JE, Soto A, Ross OA, Hulihan MM, Kachergus JM, Sando SB, White LR, Lynch T, Gibson JM, Uitti RJ, Wszolek ZK, Aasly JO, Farrer MJ. Fine-mapping and candidate gene investigation within the PARK10 locus. Eur J Hum Genet 2009 Mar; 17(3):336-43. Epub 2008 Oct 15.
    View PubMed
14. Wider C, Dachsel JC, Soto AI, Heckman MG, Diehl NN, Yue M, Lincoln S, Aasly JO, Haugarvoll K, Trojanowski JQ, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Gibson JM, Lynch T, Dickson DW, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression. Mov Disord 2009 Feb 15; 24(3):455-9.
    View PubMed
15. Vilarino-Guell C, Ross OA, Soto AI, Farrer MJ, Haugarvoll K, Aasly JO, Uitti RJ, Wszolek ZK. Reported mutations in GIGYF2 are not a common cause of Parkinson's disease. Mov Disord 2009 Jan 9. [Epub Ahead of print]
    View PubMed
16. Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ, Finch N, Rutherford NJ, Crook RJ, Josephs KA, Boeve BF, Knopman DS, Petersen RC, Parisi JE, Caselli RJ, Wszolek ZK, Uitti RJ, Feldman H, Hutton ML, Mackenzie IR, Graff-Radford NR, Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 2008 Dec 1; 17(23):3631-42. Epub 2008 Aug 21.
    View PubMed
17. Ross OA, Soto AI, Vilarino-Guell C, Heckman MG, Diehl NN, Hulihan MM, Aasly JO, Sando S, Gibson JM, Lynch T, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ. Genetic variation of Omi/HtrA2 and Parkinson's disease. Parkinsonism Relat Disord 2008 Nov; 14(7):539-43. Epub 2008 Sep 14.
    View PubMed
18. Ross OA, Heckman MG, Soto AI, Diehl NN, Haugarvoll K, Vilarino-Guell C, Aasly JO, Sando S, Gibson JM, Lynch T, Krygowska-Wajs A, Opala G, Barcikowska M, Czyzewski K, Uitti RJ, Wszolek ZK, Farrer MJ. Dopamine beta-hydroxylase -1021C>T association and Parkinson's disease. Parkinsonism Relat Disord 2008 Nov; 14(7):544-7. Epub 2008 Aug 22.
    View PubMed
19. Obwegeser AA, Uitti RJ, Lucas JA, Witte RJ, Turk MF, Galiano K, Wharen RE. Correlation of outcome to neurosurgical lesions: confirmation of a new method using data after microelectrode-guided pallidotomy. Br J Neurosurg 2008 Oct; 22(5):654-62.
    View PubMed
20. DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW. Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol 2008 Aug; 65(8):1074-80.
    View PubMed
21. Vilarino-Guell C, Soto AI, Young JE, Lin SC, Uitti RJ, Wszolek ZK, Farrer MJ. Susceptibility genes for restless legs syndrome are not associated with Parkinson disease. Neurology 2008 Jul 15; 71(3):222-3.
    View PubMed
22. Fujishiro H, Ferman TJ, Boeve BF, Smith GE, Graff-Radford NR, Uitti RJ, Wszolek ZK, Knopman DS, Petersen RC, Parisi JE, Dickson DW. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol 2008 Jul; 67(7):649-56.
    View PubMed
23. Wider C, Uitti RJ, Wszolek ZK, Fang JY, Josephs KA, Baker MC, Rademakers R, Hutton ML, Dickson DW. Progranulin gene mutation with an unusual clinical and neuropathologic presentation. Mov Disord 2008 Jun 15; 23(8):1168-73.
    View PubMed
24. Haugarvoll K, Rademakers R, Kachergus JM, Nuytemans K, Ross OA, Gibson JM, Tan EK, Gaig C, Tolosa E, Goldwurm S, Guidi M, Riboldazzi G, Brown L, Walter U, Benecke R, Berg D, Gasser T, Theuns J, Pals P, Cras P, De Deyn PP, Engelborghs S, Pickut B, Uitti Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 2008 Apr 15; 70(16 Pt 2):1456-60. Epub 2008 Mar 12.
    View PubMed
25. Imamura A, Geda YE, Slowinski J, Wszolek ZK, Brown LA, Uitti RJ. Medications used to treat Parkinson's disease and the risk of gambling. Eur J Neurol 2008 Apr; 15(4):350-4. Epub 2008 Feb 26.
    View PubMed
26. Slowinski J, Imamura A, Uitti RJ, Pooley RA, Strongosky AJ, Dickson DW, Broderick DF, Wszolek ZK. MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol 2008 Jan; 255(1):37-44. Epub 2007 Dec 19.
    View PubMed
27. Ross OA, Haugarvoll K, Stone JT, Heckman MG, White LR, Aasly JO, Mark Gibson J, Lynch T, Wszolek ZK, Uitti RJ, Farrer MJ. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism Relat Disord 2007 Oct; 13(7):386-8. Epub 2007-04-02.
    View PubMed
28. Ross OA, Haugarvoll K, Stone JT, Heckman MG, White LR, Aasly JO, Mark Gibson J, Lynch T, Wszolek ZK, Uitti RJ, Farrer MJ. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism Relat Disord 2007 Oct; 13(7):386-8. Epub 2007 Apr 02.
    View PubMed
29. Ross OA, Haugarvoll K, Stone JT, Heckman MG, White LR, Aasly JO, Mark Gibson J, Lynch T, Wszolek ZK, Uitti RJ, Farrer MJ. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism Relat Disord 2007 Oct; 13(7):386-8. Epub 2007 Apr 02.
    View PubMed
30. Whaley NR, Putzke JD, Baba Y, Wszolek ZK, Uitti RJ. Essential tremor: Phenotypic expression in a clinical cohort. Parkinsonism Relat Disord 2007 Aug; 13(6):333-9. Epub 2007 Feb 08.
    View PubMed
31. Baba Y, Baker MC, Le Ber I, Brice A, Maeck L, Kohlhase J, Yasuda M, Stoppe G, Bugiani O, Sperfeld AD, Tsuboi Y, Uitti RJ, Farrer MJ, Ghetti B, Hutton ML, Wszolek ZK. Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation. J Neural Transm 2007 Jul; 114(7):947-50. Epub 2007 Feb 23.
    View PubMed
32. Arvanitakis Z, Witte RJ, Dickson DW, Tsuboi Y, Uitti RJ, Slowinski J, Hutton ML, Lin SC, Boeve BF, Cheshire WP, Pooley RA, Liss JM, Caviness JN, Strongosky AJ, Wszolek ZK. Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Parkinsonism Relat Disord 2007 May; 13(4):230-9 Epub 2006 Dec 29.
    View PubMed
33. Baba Y, Uitti RJ, Boylan KB, Uehara Y, Yamada T, Farrer MJ, Couchon E, Batish SD, Wszolek ZK. Aprataxin (APTX) gene mutations resembling multiple system atrophy. Parkinsonism Relat Disord 2007 Apr; 13(3):139-42.
    View PubMed
34. Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, Tuite P, Calne DB, Bigio EH, Uitti RJ, Wszolek ZK, Golbe LI, Caselli RJ, Graff-Radford N, Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J Hum Genet 2007 Apr; 80(4):769-78. Epub 2007 Mar 08.
    View PubMed
35. Slowinski JL, Putzke JD, Uitti RJ, Lucas JA, Turk MF, Kall BA, Wharen RE. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease. J Neurosurg 2007 Apr; 106(4):626-32.
    View PubMed
36. Haugarvoll K, Toft M, Ross OA, Stone JT, Heckman MG, White LR, Lynch T, Gibson JM, Wszolek ZK, Uitti RJ, Aasly JO, Farrer MJ. ELAVL4, PARK10, and the Celts. Mov Disord 2007 Mar 15; 22(4):585-7.
    View PubMed
37. Slowinski J, Dominik J, Uitti RJ, Ahmed Z, Dickson DD, Wszolek ZK. Frontotemporal dementia and Parkinsonism linked to chromosome 17 with the N279K tau mutation. Neuropathology 2007 Feb; 27(1):73-80.
    View PubMed
38. Josephs KA, Ahmed Z, Katsuse O, Parisi JF, Boeve BF, Knopman DS, Petersen RC, Davies P, Duara R, Graff-Radford NR, Uitti RJ, Rademakers R, Adamson J, Baker M, Hutton ML, Dickson DW. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 2007 Feb; 66(2):142-51.
    View PubMed
39. Ross OA, Haugarvoll K, Stone JA, Heckman MG, White LR, Aasly JO, Gibson JM, Lynch T, Wszolek ZK, Uitti RJ, Farrer MJ. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism & Related Disorders 2007; 13(7):386-8.
    View PubMed
40. Ross OA, Haugarvoll K, Stone JT, Heckman MG, White LR, Aasly JO, Gibson JM, Lynch T, Wszolek ZK, Uitti RJ, Farrer MJ. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism & Related Disorders 2007; 13(7):386-8.
    View PubMed
41. Arvanitakis Z, Witte RJ, Dickson DW, Tsuboi Y, Uitti RJ, Slowinski J, Hutton ML, Lin SC, Boeve BF, Cheshire WP, Pooley RA, Liss JM, Caviness JN, Strongosky AJ, Wszolek ZK. Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Parkinsonism Relat Disord. Epub ahead of print. 2006 Dec 28.
42. Imamura A, Uitti RJ, Wszolek ZK. Dopamine agonist therapy for Parkinson disease and pathological gambling. Parkinsonism Relat Disord 2006 Dec; 12(8):506-8. Epub 2006 May 24.
    View PubMed
43. Ferman TJ, Smith GE, Boeve BF, Graff-Radford NR, Lucas JA, Knopman DS, Petersen RC, Ivnik RJ, Wszolek Z, Uitti R, Dickson DW. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease. Clin Neuropsychol 2006 Dec; 20(4):623-36.
    View PubMed
44. Putzke JD, Whaley NR, Baba Y, Wszolek ZK, Uitti RJ. Essential tremor: predictors of disease progression in a clinical cohort. J Neurol Neurosurg Psychiatry 2006 Nov; 77(11):1235-7.
    View PubMed
45. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R, Josephs K, Pickering-Brown SM, Graff-Radford N, Uitti R, Dickson D, Wszolek Z, Gonzalez J, Beach TG, Bigio E, Johnson N, Weintraub S, Mesulam M, White Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006 Oct 15; 15(20):2988-3001.
    View PubMed
46. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R, Josephs K, Pickering-Brown SM, Graff-Radford N, Uitti R, Dickson D, Wszolek Z, Gonzalez J, Beach TG, Bigio E, Johnson N, Weintraub S, Mesulam M, White Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006 Oct 15; 15(20):2988-3001. Epub 2006 Sep 01.
    View PubMed
47. Ishihara L, Warren L, Gibson R, Amouri R, Lesage S, Durr A, Tazir M, Wszolek ZK, Uitti RJ, Nichols WC, Griffith A, Hattori N, Leppert D, Watts R, Zabetian CP, Foroud TM, Farrer MJ, Brice A, Middleton L, Hentati F. Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations. Arch Neurol 2006 Sep; 63(9):1250-4.
    View PubMed
48. Wszolek ZK, Baba Y, Mackenzie IR, Uitti RJ, Strongosky AJ, Broderick DF, Baker MC, Melquist S, Hutton ML, Tsuboi Y, Allanson JE, Carr J, Kumar A, Calne SM, Miklossy J, McGeer PL, Calne DB, Stoessl AJ. Autosomal dominant dystonia-plus with cerebral calcifications. Neurology 2006 Aug 22; 67(4):620-5.
    View PubMed
49. Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, Moro E, Ondo W, Pahwa R, Poewe W, Troster AI, Uitti R, Voon V. Deep brain stimulation: preoperative issues. Mov Disord 2006 Jun; 21 Suppl 14:S171-96.
    View PubMed
50. Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ. Progressive supranuclear palsy: phenotypic sex differences in a clinical cohort. Mov Disord 2006 May; 21(5):689-92.
    View PubMed
51. Baba Y, Ghetti B, Baker MC, Uitti RJ, Hutton ML, Yamaguchi K, Bird T, Lin W, DeLucia MW, Dickson DW, Wszolek ZK. Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred. Acta Neuropathol 2006 Apr; 111(4):300-11. Epub 2006 Mar 08.
    View PubMed
52. Baba Y, Markopoulou K, Putzke JD, Whaley NR, Farrer MJ, Wszolek ZK, Uitti RJ. Phenotypic commonalities in familial and sporadic Parkinson disease. Arch Neurol 2006 Apr; 63(4):579-83.
    View PubMed
53. Josephs KA, Katsuse O, Beccano-Kelly DA, Lin WL, Uitti RJ, Fujino Y, Boeve BF, Hutton ML, Baker MC, Dickson DW. Atypical progressive supranuclear palsy with corticospinal tract degeneration. J Neuropathol Exp Neurol 2006 Apr; 65(4):396-405.
    View PubMed
54. Di Fonzo A, Tassorelli C, De Mari M, Chien HF, Ferreira J, Rohe CF, Riboldazzi G, Antonini A, Albani G, Mauro A, Marconi R, Abbruzzese G, Lopiano L, Fincati E, Guidi M, Marini P, Stocchi F, Onofrj M, Toni V, Tinazzi M, Fabbrini G, Lamberti P, Vanacore N, Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet 2006 Mar; 14(3):322-31.
    View PubMed
55. Di Fonzo A, Tassorelli C, De Mari M, Chien HF, Ferreira J, Rohe CF, Riboldazzi G, Antonini A, Albani G, Mauro A, Marconi R, Abbruzzese G, Lopiano L, Fincati E, Guidi M, Marini P, Stocchi F, Onofrj M, Toni V, Tinazzi M, Fabbrini G, Lamberti P, Vanacore N, Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet 2006 Mar; 14(3):322-31.
    View PubMed
56. Uchikado H, DelleDonne A, Uitti R, Dickson DW. Coexistence of PSP and MSA: a case report and review of the literature. Acta Neuropathol 2006 Feb; 111(2):186-92. Epub 2006 Feb 03.
    View PubMed
57. Mata IF, Bodkin CL, Adler CH, Lin SC, Uitti RJ, Farrer MJ, Wszolek ZK. Genetics of restless legs syndrome. Parkinsonism Relat Disord 2006 Jan; 12(1):1-7.
    View PubMed
58. Whaley NR, Uitti RJ, Dickson DW, Farrer MJ, Wszolek ZK. Clinical and pathologic features of families with LRRK2-associated Parkinson's disease. J Neural Transm Suppl 2006; (70):221-9.
    View PubMed
59. Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Rudolph A, Shults CW, Foroud T, Nichols WC, Shults C, Marshall F, Oakes D, Shinaman A, Marder K, Conneally PM, Lyons K, Siemers E, Factor S, Higgins D, Evans S, Shill H, Stacy M, Danielson J, Mutations in LRRK2 other than G2019S are rare in a north-American based sample of familial Parkinson's didease. Mov Disord 2006; 21(12):2257-60.
    View PubMed
60. Uitti RJ, Wszolek ZK. Concerning neuroprotective therapy for Parkinson's disease. J Neural Transm Suppl 2006; (70):433-7.
    View PubMed
61. Adams JR, van Netten H, Schulzer M, Mak E, Mckenzie J, Strongosky A, Sossi V, Ruth TJ, Lee CS, Farrer M, Gasser T, Uitti RJ, Calne DB, Wszolek ZK, Stoessl AJ. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation. Brain 2005 Dec; 128(Part 12):2777-85.
    View PubMed
62. Baba Y, Putzke JD, Whaley NR, Wszolek ZK, Uitti RJ. Gender and the Parkinson's disease phenotype. J Neurol 2005 Oct; 252(10):1201-5.
    View PubMed
63. Baba Y, Uitti RJ. Fragile X-associated tremor/ataxia syndrome and movements disorders. Curr Opin Neurol 2005 Aug; 18(4):393-8.
    View PubMed
64. Tsuboi Y, Josephs KA, Boeve BF, Litvan I, Caselli RJ, Caviness JN, Uitti RJ, Bott AD, Dickson DW. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord 2005 Aug; 20(8):982-8.
    View PubMed
65. Wharen RE Jr, Putzke JD, Uitti RJ. Deep brain stimulation lead fixation: a comparative study of the Navigus and Medtronic burr hole fixation device. Clin Neurol Neurosurg 2005 Aug; 107(5):393-5. Epub 2004 Dec 15.
    View PubMed
66. Uitti RJ, Baba Y, Whaley NR, Wszolek ZK, Putzke JD. Parkinson disease - Handedness predicts asymmetry. Neurology 2005 Jun 14; 64(11):1925-30.
    View PubMed
67. Baba Y, Tsuboi Y, Baker MC, Uitti RJ, Hutton ML, Dickson DW, Farrer M, Putzke JD, Woodruff BK, Ghetti B, Murrell JR, Boeve BF, Petersen RC, Verpillat P, Brice A, Delisle MB, Rascol O, Arima K, Dysken MW, Yasuda M, Kobayashi T, Sunohara N, Komure O, Kuno The effect of tau genotype on clinical features in FTDP-17. Parkinsonism Relat Disord 2005 Jun; 11(4):205-8.
    View PubMed
68. Baba Y, Broderick DF, Uitti RJ, Hutton ML, Wszolek ZK. Heredofamilial brain calcinosis syndrome. Mayo Clin Proc 2005 May; 80(5):641-51.
    View PubMed
69. Baba Y, Uitti RJ, Farrer MJ, Wszolek ZK. Sporadic SCA8 mutation resembling corticobasal degeneration. Parkinsonism Relat Disord 2005 May; 11(3):147-50.
    View PubMed
70. Putzke JD, Uitti RJ, Obwegeser AA, Wszolek ZK, Wharen RE. Bilateral thalamic deep brain stimulation: midline tremor control. J Neurol Neurosurg Psychiatry 2005 May; 76(5):684-90.
    View PubMed
71. Uitti RJ, Baba Y, Wszolek ZK, Putzke DJ. Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort. Parkinsonism Relat Disord 2005 May; 11(3):139-45.
    View PubMed
72. Toft M, Aasly J, Bisceglio G, Adler CH, Uitti RJ, Krygowska-Wajs A, Lynch T, Wszolek ZK, Farrer MJ. Parkinsonism, FXTAS, and FMR1 premutations. Mov Disord 2005 Feb; 20(2):230-3.
    View PubMed
73. Baba Y, Kuroiwa A, Uitti RJ, Wszolek ZK, Yamada T. Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism Relat Disord 2005; 11(8):493-8.
    View PubMed
74. Uitti RJ, Calne DB, Dickson DW, Wszolek ZK. Is the neuropathological 'gold standard' diagnosis dead? - Implications of clinicopathological findings in an autosomal dominant neurodegenerative disorder. Parkinsonism Relat Disord 2004 Dec; 10(8):461-3.
    View PubMed
75. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T. Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 2004 Nov 18; 44(4):601-7.
    View PubMed
76. Putzke JD, Wharen RE, Obwegeser AA, Wszolek ZK, Lucas JA, Turk MF, Uitti RJ. Thalamic deep brain stimulation for essential tremor: Recommendations for long-term outcome analysis. Can J Neurol Sci 2004 Aug; 31(3):333-42.
    View PubMed
77. Wszolek ZK, Pfeiffer RF, Tsuboi Y, Uitti RJ, McComb RD, Stoessl AJ, Strongosky AJ, Zimprich A, Muller-Myhsok B, Farrer MJ, Gasser T, Calne DB, Dickson DW. Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 2004 May 11; 62(9):1619-22.
    View PubMed
78. Zimprich A, Muller-Myhsok B, Farrer M, Leitner P, Sharma M, Hulihan M, Lockhart P, Strongosky A, Kachergus J, Calne DB, Stoessl J, Uitti RJ, Pfeiffer RF, Trenkwalder C, Homann N, Ott E, Wenzel K, Asmus F, Hardy J, Wszolek Z, Gasser T. The PARK8 locus in autosomal dominant parkinsonism: Confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet 2004 Jan; 74(1):11-9.
    View PubMed
79. Putzke JD, Wharen RE, Wszolek ZK, Turk MF, Strongosky AJ, Uitti RJ. Thalamic deep brain stimulation for tremor-predominant Parkinson's disease. Parkinsonism & Related Disorders 2003 Dec; 10(2):81-8.
    View PubMed
80. Furtado S, Pfeiffer RF, Uitti RJ, Wszolek ZK. Neurotherapeutics and movement disorders. World Federation of Neurology 2003 Nov 9.
81. Slowinski J, Wharen RE, Uitti RJ, Wszolek ZK, Krygowska-Wajs A, Mrowka R. [Current therapies for parkinson's disease. Part II: surgical treatment] [Article in Polish] Neurol Neurochir Pol 2003 May-Jun; 37(3):677-86.
    View PubMed
82. Krygowska-Wajs A, Hussey JM, Hulihan M, Farrer MJ, Tsuboi Y, Uitti RJ, Wszolek ZI. Two large Polish kindreds with levodopa-responsive Parkinsonism not linked to known Parkinsonian genes and loci. Parkinsonism & Related Disorders 2003 Mar; 9(4):193-200.
    View PubMed
83. Uitti RJ, Wszolek ZK. Dopamine agonists, sleep disorders, and driving in Parkinson's disease. Adv Neurol 2003; 91:343-9.
    View PubMed
84. Wszolek ZK, Tsuboi Y, Farrer M, Uitti RJ, Hutton ML. Hereditary tauopathies and parkinsonism. Adv Neurol 2003; 91:153-63.
    View PubMed
85. Tsuboi Y, Baker M, Hutton ML, Uitti RJ, Rascol O, Delisle MB, Soulages X, Murrell JR, Ghetti B, Yasuda M, Komure O, Kuno S, Arima K, Sunohara N, Kobayashi T, Mizuno Y, Wszolek ZK. Clinical and genetic studies of families with the tau N279K mutation (FTDP-17). Neurology 2002 Dec 10; 59(11):1791-3.
    View PubMed
86. Uitti RJ, Tsuboi Y, Pooley RA, Putzke JD, Turk MF, Wszolek ZK, Witte RJ, Wharen RE. Magnetic resonance imaging and deep brain stimulation. Neurosurgery 2002 Dec; 51(6):1423-8.
    View PubMed
87. Tsuboi Y, Uitti RJ, Delisle MB, Ferreira JJ, Brefel-Courbon C, Rascol O, Ghetti B, Murrell JR, Hutton M, Baker M, Wszolek ZK. Clinical features and disease haplotypes of individuals with the N279K tau gene mutation - A comparison of the pallidopontonigral degeneration kindred and a French family. Arch Neurol 2002 Jun; 59(6):943-50.
    View PubMed
88. Wszolek ZK, Gwinn-Hardy K, Wszolek EK, Muenter MD, Pfeiffer RF, Rodnitzky RL, Uitti RJ, McComb RD, Gasser T, Dickson DW. Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism. Acta Neuropathol (Berl) 2002 Apr; 103(4):344-50.
    View PubMed
89. Pal PK, Wszolek ZK, Uitti R, Markopoulou K, Calne SM, Stoessl AJ, Calne DB. Positron emission tomography of dopamine pathways in familial Parkinsonian syndromes. Parkinsonism & Related Disorders 2001 Sep; 8(1):51-56.
    View PubMed
90. Wszolek ZK, Tsuboi Y, Uitti RJ, Reed L, Hutton ML, Dickson DW. Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation. Brain 2001 Aug; 124(Pt 8):1666-70.
    View PubMed
91. Pal PK, Wszolek ZK, Kishore A, de la Fuente-Fernandez R, Sossi V, Uitti RJ, Dobko T, Stoessl AJ. Positron emission tomography in Pallido-Ponto-Nigral degeneration (PPND) family (frontotemporal dementia with Parkinsonism linked to chromosome 17 and point mutation in Tau gene). Parkinsonism & Related Disorders 2001 Apr; 7(2):81-88.
    View PubMed
92. Obwegeser AA, Uitti RJ, Witte RJ, Lucas JA, Turk MF, Wharen RE Jr. Quantitative and qualitative outcome measures after thalamic deep brain stimulation to treat disabling tremors. Neurosurgery 2001 Feb; 48(2):274-81; discussion 281-4.
    View PubMed
93. Obwegeser AA, Uitti RJ, Turk MF, Wszolek UM, Flipse TR, Smallridge RC, Witte RJ, Wharen RE Jr. Simultaneous thalamic deep brain stimulation and implantable cardioverter-defibrillator. Mayo Clin Proc 2001 Jan; 76(1):87-9.
    View PubMed
94. Wszolek ZK, Uitti RJ, Markopoulou K. Familial Parkinson's disease and related conditions - Clinical genetics. Adv Neurol 2001; (86):33-43.
95. Obwegeser AA, Uitti RJ, Lucas JA, Witte RJ, Turk MF, Wharen RE Jr. Predictors of neuropsychological outcome in patients following microelectrode-guided pallidotomy for Parkinson's disease. J Neurosurg 2000 Sep; 93(3):410-20.
    View PubMed
96. Uitti RJ, Wharen RE, Duffy JR, Lucas JA, Schneider SL, Rippeth JD, Wszolek ZK, Obwegeser AA, Turk MF, Atkinson EJ. Unilateral pallidotomy for Parkinson's disease: speech, motor, and neuropsychological outcome measurements. Parkinsonism & Related Disorders 2000 Jul; 6(3):133-143.
    View PubMed
97. Obwegeser AA, Uitti RJ, Turk MF, Strongosky AJ, Wharen RE. Thalamic stimulation for the treatment of midline tremors in essential tremor patients. Neurology 2000 Jun 27; 54(12):2342-4.
    View PubMed
98. Lucas JA, Rippeth JD, Uitti RJ, Shuster EA, Wharen RE. Neuropsychological functioning in a patient with essential tremor with and without bilateral VIM stimulation. Brain & Cognition 2000 Mar; 42(2):253-67.
    View PubMed
99. Uitti RJ. Surgical treatments for Parkinson's disease. Can Fam Physician 2000 Feb; 46:368-73.
    View PubMed
100. Ahlskog JE, Uitti RJ, O'Connor MK, Maraganore DM, Matsumoto JY, Stark KF, Turk MF, Burnett OL. The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease. Mov Disord 1999 Nov; 14(6):940-6.
     View PubMed
101. Dickson DW, Liu W, Hardy J, Farrer M, Mehta N, Uitti R, Mark M, Zimmerman T, Golbe L, Sage J, Sima A, D'Amato C, Albin R, Gilman S, Yen SH. Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol 1999 Oct; 155(4):1241-51.
     View PubMed
102. Jarman PR, del Grosso N, Valente EM, Leube B, Cassetta E, Bentivoglio AR, Waddy HM, Uitti RJ, Maraganore DM, Albanese A, Frontali M, Auburger G, Bressman SB, Wood NW, Nygaard TG. Primary torsion dystonia: the search for genes is not over. Journal of Neurology, Neurosurgery & Psychiatry 1999 Sep; 67(3):395-7.
     View PubMed
103. Uemichi T, Uitti RJ, Koeppen AH, Donat JR, Benson MD. Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64. Arch Neurol 1999 Sep; 56(9):1152-5.
     View PubMed
104. Bronstein JM, DeSalles A, DeLong MR, Uitti RJ, et al. Stereotactic pallidotomy in the treatment of Parkinson's disease. Archives of Neurology 1999; 56:1064-9.
     View PubMed
105. Uitti RJ, Wszolek ZK. Medical treatment of Parkinson's disease. Neurosci News 1999; 2(3-4):36-43.
106. Wszolek ZK, Uitti RJ. The clinical genetics of Parkinson's disease. Neurosci News 1999; 2(3-4):66-72.
107. Uitti RJ, Wharen RE Jr, Turk MF. Efficacy of levodopa therapy on motor function after posteroventral pallidotomy for Parkinson's disease. Neurology 1998 Dec; 51(6):1755-7.
     View PubMed
108. Uitti RJ, Turk MF. Treatment of movement disorders in the home care setting. Home Healthcare Consultant 1998 Oct; 5(10):13-6, 19-22.
109. Uitti RJ. Medical treatment of essential tremor and Parkinson's disease. Geriatrics 1998 May; 53(5):46-8, 53-7.
     View PubMed
110. Uitti RJ. Tremor: how to determine if the patient has Parkinson's disease. Geriatrics 1998 May; 53(5):30-6.
     View PubMed
111. Finton MJ, Lucas JA, Graff-Radford NR, Uitti RJ. Analysis of visuospatial errors in patients with Alzheimer's disease or Parkinson's disease. Journal of Clinical & Experimental Neuropsychology 1998 Apr; 20(2):186-93.
     View PubMed
112. Rajput AH, Uitti RJ, Fenton ME, George D. Amantadine effectiveness in multiple system atrophy and progressive supranuclear palsy. Parkinsonism & Related Disorders 1998; 3:211-214.
113. Uitti RJ, Wharen RE Jr, Turk MF, Lucas JA, Finton MJ, Graff-Radford NR, Boylan KB, Goerss SJ, Kall BA, Adler CH, Caviness JN, Atkinson EJ. Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients. Neurology 1997 Oct; 49(4):1072-7.
     View PubMed
114. Graff-Radford NR, Lin SC, Brazis PW, Bolling JP, Liesegang TJ, Lucas JA, Uitti RJ, O'Brien PC. Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease. Mayo Clin Proc 1997 Jun; 72(6):495-504.
     View PubMed
115. Uitti RJ, Shinotoh H, Hayward M, Schulzer M, Mak E, Calne DB. "Familial Parkinson's disease"--a case-control study of families. Can J Neurol Sci 1997 May; 24(2):127-32.
     View PubMed
116. Shinotoh H, Vingerhoets FJ, Lee CS, Uitti RJ, Schulzer M, Calne DB, Tsui J. Lamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover study. Neurology 1997 May; 48(5):1282-5.
     View PubMed
117. Wszolek ZK, Vieregge P, Uitti RJ, Gasser T, Yasuhara O, McGeer P, Berry K, Calne DB, Vingerhoets FJG, Klein C, Pfeiffer RF. German-Canadian family (family A) with Parkinsonism, amyotrophy, and dementia - longitudinal observations. Parkinsonism & Related Disorders 1997; 3:125-139.
118. Rajput AH, Uitti RJ, Rajput AH, Offord KP. Timely levodopa administration prolongs survival in Parkinson's disease. Parkinsonism & Related Disorders 1997; 3:159-165.
119. Uitti RJ, Vingerhoets FJG, Hayward M, Cooper S, Snow BJ. Positron emission tomography (PET) measurements of striatal D2 receptors in untreated Parkinson's disease patients with follow-up after 6 and 12 months' treatment with Sinemet (Trademark) or Sinemet (Trademark) CR. Parkinsonism & Related Disorders 1997; 3(1):43-46.
120. Bressman SB, Warner TT, Almasy L, Uitti RJ, Greene PE, Heiman GA, Raymond D, Ford B, de Leon D, Fahn S, Kramer PL, Risch NJ, Maraganore DM, Nygaard TG, Harding AE. Exclusion of the DYT1 locus in familial torticollis. Ann Neurol 1996 Oct; 40(4):681-4.
     View PubMed
121. Di Paola R, Uitti RJ. Early detection of Parkinson's disease. Implications for treatment. Drugs & Aging 1996 Sep; 9(3):159-68.
     View PubMed
122. Uitti RJ, Rajput AH, Ahlskog JE, Offord KP, Schroeder DR, Ho MM, Prasad M, Rajput A, Basran P. Amantadine treatment is an independent predictor of improved survival in Parkinson's disease. Neurology 1996 Jun; 46(6):1551-6.
     View PubMed
123. Uitti RJ, Ahlskog JE. Comparative review of dopamine receptor agonists in Parkinson's disease. CNS Drugs 1996 May; 5(5):369-388.
124. Ahlskog JE, Uitti RJ, Low PA, Tyce GM, O'Brien JF, Nickander KK. Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease. Neurology 1996 Mar; 46(3):796-801.
     View PubMed
125. Ahlskog JE, Uitti RJ, Tyce GM, O'Brien JF, Petersen RC, Kokmen E. Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases. J Neurol Sci 1996 Mar; 136(1-2):162-8.
     View PubMed
126. Uitti RJ, Turk MF. Diagnosis and treatment of common movement disorders in nursing home residents. Nursing Home Medicine 1996; 4:149-160.
127. Gasser T, Wszolek Z, Supala A, Trofatter J, Ozelius L, Uitti RJ, Pfeiffer RF, Gusella J, Calne D, Breakefield XO. Genetic linkage studies in autosomal dominantly inherited L-DOPA responsive parkinsonism. Evaluation of candidate genes. Adv Neurol 1996; 69:87-95.
     View PubMed
128. Ahlskog JE, Uitti RJ, Low PA, Tyce GM, Nickander KK, Petersen RC, Kokmen E. No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease. Mov Disord 1995 Sep; 10(5):566-73.
     View PubMed
129. Wszolek ZK, Pfeiffer B, Fulgham JR, Parisi JE, Thompson BM, Uitti RJ, Calne DB, Pfeiffer RF. Western Nebraska family (family D) with autosomal dominant parkinsonism. Neurology 1995 Mar; 45(3 Pt 1):502-5.
     View PubMed
130. Britton JW, Uitti RJ, Ahlskog JE, Robinson RG, Kremer B, Hayden MR. Hereditary late-onset chorea without significant dementia: genetic evidence for substantial phenotypic variation in Huntington's disease. Neurology 1995 Mar; 45(3 Pt 1):443-7.
     View PubMed
131. Uitti RJ, Yasuhara O, Eisen A, Berry K, Feldman H, McGeer P, Calne DB. Neurodegenerative overlap syndrome: clinical and pathological feature of Parkinson's disease, motor neuron disease and Alzheimer's disease. Parkinsonism & Related Disorders 1995; 1:21-34.
132. Gasser T, Wszolek ZK, Trofatter J, Ozelius L, Uitti RJ, Lee CS, Gusella J, Pfeiffer RF, Calne DB, Breakefield XO. Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes. Ann Neurol 1994 Sep; 36(3):387-96.
     View PubMed
133. Uitti RJ, Snow BJ, Shinotoh H, Vingerhoets FJ, Hayward M, Hashimoto S, Richmond J, Markey SP, Markey CJ, Calne DB. Parkinsonism induced by solvent abuse. Ann Neurol 1994 May; 35(5):616-9.
     View PubMed
134. Uitti RJ, Maraganore DM. Adult onset familial cervical dystonia: report of a family including monozygotic twins. Mov Disord 1993 Oct; 8(4):489-94.
     View PubMed
135. Uitti RJ, Ahlskog JE, Maraganore DM, Muenter MD, Atkinson EJ, Cha RH, O'Brien PC. Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project. Neurology 1993 Oct; 43(10):1918-26.
     View PubMed
136. Uitti RJ, Calne DB. Pathogenesis of idiopathic parkinsonism. Eur Neurol 1993; 33(Suppl 1):6-23.
     View PubMed
137. Uitti RJ, Tanner CM, Rajput AH, Goetz CG, Klawans HL, Thiessen B. Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 1989 Oct; 12(5):375-83.
     View PubMed
138. Uitti RJ, Rajput AH, Rozdilsky B, Bickis M, Wollin T, Yuen WK. Regional metal concentrations in Parkinson's disease, other chronic neurological diseases, and control brains. Can J Neurol Sci 1989 Aug; 16(3):310-4.
     View PubMed
139. Desai HB, Rajput AH, Uitti RJ. Recurrent spinal cord ischemia due to abdominal aortic aneurysm--a case report. Angiology 1989 Jul; 40(7):682-7.
     View PubMed
140. Rajput AH, Uitti RJ, Sudhakar S, Rozdilsky B. Parkinsonism and neurofibrillary tangle pathology in pigmented nuclei. Ann Neurol 1989 Jun; 25(6):602-6.
     View PubMed
141. Uitti RJ, Donat JR, Rozdilsky B, Schneider RJ, Koeppen AH. Familial oculoleptomeningeal amyloidosis. Report of a new family with unusual features. Arch Neurol 1988 Oct; 45(10):1118-22.
     View PubMed
142. Munoz DG, Ha T, Uitti RJ. Neurite extension on dibutyryl cyclic AMP-stimulated astrocytes. Exp Neurol 1988 Sep; 101(3):374-84.
     View PubMed
143. Rajput AH, Uitti RJ, Rajput AH. Neurological disorders and services in Saskatchewan--a report based on provincial health care records. Neuroepidemiology 1988; 7(3):145-51.
     View PubMed
144. Rajput AH, Uitti RJ, Stern W, Laverty W, O'Donnell K, O'Donnell D, Yuen WK, Dua A. Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson's disease. Can J Neurol Sci 1987 Aug; 14(3 Suppl):414-8.
     View PubMed
145. Calne S, Schoenberg B, Martin W, Uitti RJ, Spencer P, Calne DB. Familial Parkinson's disease: possible role of environmental factors. Can J Neurol Sci 1987 Aug; 14(3):303-5.
     View PubMed
146. Uitti RJ, Rajput AH, Rozdilsky B, Yuen WK. Regional distribution of metals in human brain. Clinical & Investigative Medicine - Medecine Clinique et Experimentale 1987 Jan; 10(1):10-3.
147. Uitti RJ, Rajput AH. Diagnosis and treatment of Parkinson's disease and tremor. CME News 1987; 17:6-7.
148. Rajput AH, Uitti RJ, Stern W, Laverty W. Early onset Parkinson's disease and childhood environment. Adv Neurol 1987; 45:295-7.
     View PubMed
149. Rajput AH, Uitti RJ, Stern W, Laverty W. Early onset Parkinson's disease in Saskatchewan--environmental considerations for etiology. Can J Neurol Sci 1986 Nov; 13(4):312-6.
     View PubMed
150. Uitti RJ, Rajput AH. Multiple sclerosis presenting as isolated oculomotor nerve palsy. Can J Neurol Sci 1986 Aug; 13(3):270-2.
     View PubMed
151. Uitti RJ, Rajput AH, Ashenhurst EM, Rozdilsky B. Cyanide-induced parkinsonism: a clinicopathologic report. Neurology 1985 Jun; 35(6):921-5.
     View PubMed